Clinical Practice Guidelines on Intragastric Balloons in Management of Obesity (AGA, 2021)

American Gastroenterological Association

These are some of the highlights of the guidelines without analysis or commentary. For more information, go directly to the guidelines by clicking the link in the reference.

April 29, 2021

Guidelines on intragastric balloons (IGBs) in the management of obesity were published in April 2021 by the American Gastroenterological Association (AGA) in Gastroenterology.[1,2]

For obese patients (body mass index [BMI] >30 kg/m2) desiring weight loss but for whom conventional weight-loss strategies have failed, a combination of IGB placement and moderate- to high-intensity lifestyle modifications (to maintain and augment weight loss) may be more effective than lifestyle modifications alone.

Concomitant perioperative antiemetic therapy along with an intraoperative anesthetic that is unlikely to cause nausea are recommended during IGB placement, as well as postprocedure prophylactic administration of proton pump inhibitor (PPI) therapy. AGA suggests a scheduled antiemetic regimen for 2 weeks after IGB placement.

For individuals who undergo IGB therapy, AGA suggests against perioperative laboratory screening for nutritional deficiencies.

Following IGB placement, daily supplementation with 1-2 adult dose multivitamins is suggested.

Following IGB removal, subsequent weight-loss or maintenance strategies are suggested that include dietary interventions, pharmacotherapy, repeat IGB, or bariatric surgery. Use shared decision making to determine the selection of post-IGB weight-loss or maintenance methods based on a patient's individual clinical situation and comorbidities.

For more information, please go to Obesity.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.